Lantheus Holdings Depreciation & Amortization 2011-2026 | LNTH

Annual Depreciation & Amortization Lantheus Holdings

2025	2024	2023	2022	2021	2020	2019	2018	2017	2016	2015	2014	2013	2012	2011
70.1 M	64.6 M	60 M	47.9 M	42.3 M	24.7 M	13.4 M	13.9 M	19.2 M	18.3 M	19.7 M	19 M	25.8 M	-	-

All numbers in USD currency

Indicator range from annual reports

Maximum	Minimum	Average
70.1 M	13.4 M	33.8 M

Quarterly Depreciation & Amortization Lantheus Holdings

2026-Q1	2025-Q3	2025-Q2	2025-Q1	2024-Q4	2024-Q3	2024-Q2	2024-Q1	2023-Q4	2023-Q3	2023-Q2	2023-Q1	2022-Q4	2022-Q3	2022-Q2	2022-Q1	2021-Q4	2021-Q3	2021-Q2	2021-Q1	2020-Q4	2020-Q3	2020-Q2	2020-Q1	2019-Q4	2019-Q3	2019-Q2	2019-Q1	2018-Q4	2018-Q3	2018-Q2	2018-Q1	2017-Q4	2017-Q3	2017-Q2	2017-Q1	2016-Q4	2016-Q3	2016-Q2	2016-Q1	2015-Q4	2015-Q3	2015-Q2	2015-Q1	2014-Q4	2014-Q3	2014-Q2	2014-Q1	2013-Q4	2013-Q3	2013-Q2	2013-Q1	2012-Q4	2012-Q3	2012-Q2	2012-Q1	2011-Q4	2011-Q3	2011-Q2	2011-Q1
22.7 M	14.6 M	8 M	13.6 M	-	11.9 M	10.2 M	15.4 M	-	11.7 M	12.4 M	14.6 M	-	3.9 M	3.3 M	11.8 M	-	30.1 M	3.2 M	8.12 M	-	16.3 M	7.76 M	3.73 M	-	9.84 M	6.58 M	3.32 M	-	10.5 M	7.09 M	3.6 M	-	15 M	11.3 M	6.16 M	-	12.7 M	8.42 M	4.11 M	-	16.6 M	12.6 M	8.12 M	-	14.8 M	9.87 M	-	-	-	-	-	-	-	-	-	-	-	-	-

All numbers in USD currency

Indicator range from quarterly reporting

Maximum	Minimum	Average
30.1 M	3.2 M	10.7 M

Depreciation & Amortization of other stocks in the Diagnostics research industry

Issuer	Depreciation & Amortization	Price	% 24h	Market Cap	Country
Enzo Biochem ENZ	1.27 M	-	-8.98 %	$ 14.8 K	USA
Heska Corporation HSKA	14 M	-	-	$ 1.31 B	USA
Fulgent Genetics FLGT	24.1 M	$ 18.5	1.04 %	$ 569 M	USA
Celcuity CELC	167 K	$ 92.59	-	$ 4.33 B	USA
Akumin AKU	98.2 M	-	-17.87 %	$ 25.9 M	Canada
Co-Diagnostics CODX	1.11 M	$ 4.5	-	$ 5.99 M	USA
Castle Biosciences CSTL	40.8 M	$ 21.08	-	$ 611 M	USA
Aspira Women's Health AWH	112 K	-	-6.19 %	$ 10.5 M	USA
Accelerate Diagnostics AXDX	1.4 M	-	-61.36 %	$ 2.46 M	USA
Biocept BIOC	1.66 M	-	-13.05 %	$ 7.29 M	USA
Guardant Health GH	39.7 M	$ 130.12	-	$ 16.3 B	USA
CareDx, Inc CDNA	15 M	$ 22.75	-	$ 1.21 B	USA
Chembio Diagnostics CEMI	2.55 M	-	0.22 %	$ 16.8 M	USA
ICON Public Limited Company ICLR	383 M	$ 151.82	-	$ 11.9 B	Irlanda
Check-Cap Ltd. CHEK	161 K	-	-	$ 9.42 M	Israel
Illumina ILMN	270 M	$ 160.03	-	$ 24.8 B	USA
Interpace Biosciences IDXG	425 K	$ 1.74	3.57 %	$ 7.7 M	USA
HTG Molecular Diagnostics HTGM	587 K	-	-20.0 %	$ 1.06 M	USA
Global Cord Blood Corporation CO	43.3 M	-	-	$ 399 M	China
DermTech DMTK	200 K	-	-11.32 %	$ 2.94 M	USA
Charles River Laboratories International CRL	403 M	$ 189.85	-	$ 9.41 B	USA
Medpace Holdings MEDP	27.2 M	$ 466.79	-	$ 13.5 B	USA
NeoGenomics NEO	36.1 M	$ 11.44	-	$ 1.47 B	USA
Exact Sciences Corporation EXAS	125 M	-	-	$ 19.8 B	USA
Mettler-Toledo International MTD	51.1 M	$ 1 162.79	-0.02 %	$ 24 B	Schweiz
National Research Corporation NRC	7.62 M	$ 19.75	-	$ 442 M	USA
Myriad Genetics MYGN	53.7 M	$ 4.54	-	$ 420 M	USA
Pacific Biosciences of California PACB	13 M	$ 1.37	-	$ 411 M	USA
Natera NTRA	41.8 M	$ 222.82	-	$ 30.5 B	USA
Personalis PSNL	10 M	$ 9.75	-	$ 870 M	USA
Koninklijke Philips N.V. PHG	1.12 B	$ 26.5	-	$ 25.1 B	Niderland
Senseonics Holdings SENS	1.51 M	$ 7.43	-	$ 310 M	USA
QIAGEN N.V. QGEN	194 M	-	-	$ 10.6 B	Niderland
Soleno Therapeutics SLNO	2.02 M	-	-	$ 2.69 B	USA
Biomerica BMRA	87 K	$ 2.05	-	$ 4.71 M	USA
Laboratory Corporation of America Holdings LH	681 M	$ 271.24	-	$ 22.6 B	USA
Twist Bioscience Corporation TWST	24.9 M	$ 70.06	-	$ 4.19 B	USA
Waters Corporation WAT	88.1 M	$ 371.15	-	$ 22.1 B	USA
Thermo Fisher Scientific TMO	1.05 B	$ 494.07	-	$ 186 B	USA
Motus GI Holdings MOTS	451 K	-	-34.28 %	$ 263 K	Israel
Neogen Corporation NEOG	119 M	$ 9.29	-	$ 2.01 B	USA
Quest Diagnostics Incorporated DGX	570 M	$ 204.53	0.01 %	$ 22.7 B	USA